Double-Blind, Placebo-Controlled Study for the Effect of Lyophilized Herring-Roe Powder on Lipid Metabolism Improvement - The Effect of Daily Ingestion of Herring-Roe Powder on Dyslipidemia

Hokkaido Information University0 个研究点目标入组 32 人开始时间: 2015年4月8日最近更新: 2023年10月17日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方: Hokkaido Information University
入组人数: 32

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 40years-old 至 70years-old（—）
性别: All

入选标准

未提供

排除标准

•1.Subjects who are under treatment and medication for chronic ailments (especially diseases related to cancer, liver, kidney, heart, digestive system, diabetes, dyslipidemia, hypertension, mental disorder, etc.) 2.Subjects with serious cerebrovascular, cardiac, hepatic, renal and / or gastrointestinal diseases, or affected with an infectious disease which is required to report to the authorities 3. Subjects who have a major surgical history related to digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 4. Subjects with familial hypercholesterolemia. 5. Subjects with frequent complaints of pre- or post-menopausal symptoms 6. Subjects with unusually high and/or low blood pressure, or with abnormal hematological data 7. Subjects with serious anemia 8. Subjects who are at risk of having allergic reactions to drugs or foods (especially fish-roe, soybean) 9. Subjects who take regularly thyroid drugs, or drugs containing EPA, statin, fibrate, ezetibime and/or steroids, etc. Or functional foods and/or supplements (EPA, DHA, MCT, phytosterol, sesamin, turmeric, polyphenols, dietary fiber, etc.) which would affect the blood lipids. 10. Heavy smokers, alcohol addicts or subjects with irregular lifestyle 11. Subjects who donate either 400ml whole blood within 12 weeks or 200ml within 4 weeks, or blood component within 2 weeks prior to this study 12. Subjects who are pregnant or expected to be pregnant, or lactating during the study 13. Subjects who participate in other clinical trials within the last one month prior to the current clinical trial 14. Any other medical reasons judged by the principal investigator

研究者

发起方

Hokkaido Information University

相似试验

已完成

不适用

Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of Yabukita green tea and Sun Rouge green tea on the Improvement of Blood Pressure and Eyestrai

JPRN-UMIN000018469Hokkaido Information University108

已完成

3 期

Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of the Plum Extract on the Improvement of Blood Pressure and Blood FlowHealthy adults

JPRN-UMIN000017917Hokkaido Information University52

已完成

3 期

Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of the Tea Containing Enzymatically Modified Rutin on Lipid Metabolism ImprovementHealthy adults

JPRN-UMIN000017204Hokkaido Information University64

已完成

3 期

Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of the Mulberry Leaf Tea on the improvement of Liver FunctioHealthy adults

JPRN-UMIN000017916Hokkaido Information University32

进行中（未招募）

1 期

Study comparing the effect of MIN-102 and an inactive substance to learn more about the effects of the MIN-102 on Biochemical, Imaging, Neurophysiological, and Clinical Markers in Patients with Friedreich’s Ataxia, in which neither investigators nor subjects know what treatment the subject is receiving.Friedreich’s AtaxiaMedDRA version: 20.0Level: PTClassification code 10017374Term: Friedreich's ataxiaSystem Organ Class: 10010331 - Congenital, familial and genetic disorders

EUCTR2018-004405-64-ESMinoryx Therapeutics BE, SA39